Hinge Health (HNGE) Short-term Investments (2024 - 2026)

Hinge Health has disclosed Short-term Investments across 3 years of filings, most recently posting $129.2 million for Q1 2026.

• Short-term Investments for Q1 2026 came in at $129.2 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $129.2 million (changed N/A YoY), and the FY2025 annual result was $155.9 million, down 5.98% from the prior year.
• Short-term Investments came in at $129.2 million for Q1 2026 at Hinge Health, down from $155.9 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $218.7 million in Q3 2025 to a low of $129.2 million in Q1 2026.
• The 3-year median for Short-term Investments is $165.8 million (2024), against an average of $169.1 million.
• Peak annual rise in Short-term Investments reached 5.98% in 2025, while the deepest fall reached 5.98% in 2025.
• Hinge Health's Short-term Investments stood at $165.8 million in 2024, then declined by 5.98% to $155.9 million in 2025, then declined by 17.11% to $129.2 million in 2026.
• The last three Short-term Investments figures came in at $129.2 million (Q1 2026), $155.9 million (Q4 2025), and $218.7 million (Q3 2025), per Business Quant data.